| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |